Skip to Main Content

Javid Moslehi

MD

Cardiologist
Chief, Cardio-Oncology and Immunology

About me

Dr. Javid Moslehi is a cardiologist who specializes in the cardiovascular health of cancer patients, cancer survivors and patients with immunological or metabolic problems that affect cardiovascular health. He serves as chief of UCSF's cardio-oncology and immunology section.

Moslehi's research focuses on how diseases of the cardiovascular system impact cancer patients and survivors. He is also interested in inflammatory heart conditions, such as myocarditis.

Moslehi earned his medical degree from the University of Connecticut School of Medicine. He completed a residency in internal medicine at the Johns Hopkins Hospital. At Brigham and Women's Hospital, he completed a fellowship in cardiology and a postdoctoral research fellowship in oncology. His career includes directing cardio-oncology programs at the Dana-Farber Cancer Institute and Vanderbilt University Medical Center. He is the UCSF William Grossman Distinguished Professor in Cardiology.

  • Education

    University of Connecticut School of Medicine, MD, 2001

  • Residencies

    Johns Hopkins Hospital, Internal Medicine, 2004

  • Fellowships

    Brigham & Women's Hospital, Cardiovascular and Vascular Medicine, 2007

  • Academic Title

    Professor

Where I see patients (3)

    My reviews

    4.8

    Overall Experience
    33 Ratings
    About our process
    Nov 02, 2023
    Outstanding physician in every respect
    Jul 27, 2023
    Extremely helpful in every way
    Apr 20, 2023
    Doctor talked to and looked at daughter more than patient. Although elderly, patient should be focus of discussion and always included.
    Mar 23, 2023
    Dr Moslehi is wonderful
    Mar 12, 2023
    Dr Moslehi had terrible listening skills. When he asked me a question, I would start to answer and he repeatedly interrupted me. I don't think I finished a single sentence before he started talking.
    Feb 18, 2023
    I felt he was only interested in prescribing drugs, not with any program or process.

    Share